Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Sell
9,415
-1,062
-10% -$193K 0.01% 580
2026
Q1
$1.61M Sell
10,477
-3,636
-26% -$493K 0.01% 622
2025
Q4
$1.6M Buy
+14,113
New +$1.72M 0.01% 609
2025
Q1
$4.9M Buy
32,023
+5,751
+22% +$904K 0.03% 426
2024
Q4
$3.93M Sell
26,272
-96,997
-79% -$15.2M 0.02% 442
2024
Q3
$20.2M Buy
123,269
+108,446
+732% +$16M 0.1% 206
2024
Q2
$2.05M Buy
14,823
+215
+1% +$29.6K 0.01% 546
2024
Q1
$2.02M Sell
14,608
-422
-3% -$50.6K 0.01% 566
2023
Q4
$1.57M Sell
15,030
-1,237
-8% -$114K 0.01% 598
2023
Q3
$1.54M Sell
16,267
-494
-3% -$50.4K 0.01% 566
2023
Q2
$1.36M Hold
16,761
0.01% 586
2023
Q1
$1.36M Sell
16,761
-240
-1% -$19.2K 0.01% 587
2022
Q4
$1.27M Sell
17,001
-523,262
-97% -$40.6M 0.01% 604
2022
Q3
$44.7M Sell
540,263
-2,335
-0.4% -$205K 0.28% 98
2022
Q2
$43.4M Buy
542,598
+150,395
+38% +$15.2M 0.25% 98
2022
Q1
$44.4M Buy
392,203
+113,437
+41% +$12.7M 0.22% 111
2021
Q4
$31.7M Sell
278,766
-8,046
-3% -$865K 0.15% 158
2021
Q3
$33.3M Sell
286,812
-2,130
-0.7% -$267K 0.17% 141
2021
Q2
$34.8M Sell
288,942
-149,734
-34% -$17.7M 0.18% 142
2021
Q1
$47.3M Buy
438,676
+12,622
+3% +$1.4M 0.25% 104
2020
Q4
$50M Buy
426,054
+111,127
+35% +$11.3M 0.28% 101
2020
Q3
$27M Buy
314,927
+10,271
+3% +$877K 0.16% 150
2020
Q2
$24.1M Sell
304,656
-105,305
-26% -$8.22M 0.15% 162
2020
Q1
$30.8M Hold
409,961
0.14% 200
2019
Q4
$30.8M Buy
409,961
+194,857
+91% +$12.9M 0.14% 200
2019
Q3
$12.3M Buy
215,104
+147,016
+216% +$8.54M 0.06% 332
2019
Q2
$3.83M Sell
68,088
-261,085
-79% -$13.5M 0.02% 521
2019
Q1
$17.9M Buy
329,173
+5,116
+2% +$283K 0.08% 315
2018
Q4
$16.7M Sell
324,057
-334,761
-51% -$21.4M 0.08% 303
2018
Q3
$47.2M Buy
658,818
+321,054
+95% +$22.7M 0.19% 170
2018
Q2
$23.5M Buy
337,764
+304,693
+921% +$20.4M 0.1% 275
2018
Q1
$2.39M Hold
33,071
0.01% 625
2017
Q4
$2.39M Buy
33,071
+2,829
+9% +$174K 0.01% 625
2017
Q3
$1.79M Sell
30,242
-333,882
-92% -$20.1M 0.01% 673
2017
Q2
$24.7M Hold
364,124
0.12% 259
2017
Q1
$24.7M Buy
364,124
+174,698
+92% +$11.6M 0.12% 259
2016
Q4
$12.2M Buy
189,426
+180,629
+2,053% +$11.2M 0.07% 342
2016
Q3
$580K Buy
8,797
+3,012
+52% +$212K ﹤0.01% 885
2016
Q2
$447K Buy
5,785
+1,879
+48% +$142K ﹤0.01% 958
2016
Q1
$286K Buy
3,906
+1,523
+64% +$103K ﹤0.01% 1066
2015
Q4
$166K Sell
2,383
-413
-15% -$30.3K ﹤0.01% 1226
2015
Q3
$202K Buy
2,796
+567
+25% +$44K ﹤0.01% 1174
2015
Q2
$175K Sell
2,229
-1,020
-31% -$83.8K ﹤0.01% 1261
2015
Q1
$262K Buy
3,249
+3,075
+1,767% +$236K ﹤0.01% 1169
2014
Q4
$12K Sell
174
-5,090
-97% -$383K ﹤0.01% 2166
2014
Q3
$383K Buy
5,264
+1,560
+42% +$114K ﹤0.01% 961
2014
Q2
$266K Sell
3,704
-632
-15% -$43.9K ﹤0.01% 1073
2014
Q1
$297K Sell
4,336
-343
-7% -$22.8K ﹤0.01% 1050
2013
Q4
$295K Buy
4,679
+3,547
+313% +$208K ﹤0.01% 1027
2013
Q3
$64K Sell
1,132
-204
-15% -$11.7K ﹤0.01% 1522
2013
Q2
$80K Buy
+1,336
New +$83.4K ﹤0.01% 1391

Other funds holding DVA

Glenmede Trust's DVA Position: Q2 2026 in Review

Glenmede Trust reduced its DaVita (DVA) stake by 10% in Q2 2026, selling an estimated $193K and leaving 9,415 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #580.

Glenmede Trust first reported a position in DVA in Q2 2013 and has held it in 51 quarters since. The position peaked at $50M in Q4 2020. 630 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Glenmede Trust held 9,415 shares of DaVita worth $2.09M as of Q2 2026.
  • Glenmede Trust sold 1,062 DaVita shares in Q2 2026, an estimated $193K.
  • DaVita made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #580 holding.
  • Glenmede Trust first reported a position in DaVita in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's DaVita position peaked at $50M in Q4 2020.
  • 630 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.